Trials / Enrolling By Invitation
Enrolling By InvitationNCT06683118
Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis
A PROSPECTIVE, MULTI-CENTER, OPEN-LABEL, SUPERIORITY, RANDOMIZED, CONTROLLED REGISTRATION TRIAL OF THE RAPAMYCIN NEUROVASCULAR BALLOON CATHETER FOR THE TREATMENT OF SYMPTOMATIC CEREBRAL ATHEROSCLEROTIC STENOSIS
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 212 (estimated)
- Sponsor
- MicroPort NeuroTech Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the trail is to determine whether DCB is superior to conventional balloon in treating cerebral atherosclerotic stenosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rapamycin neurovascular Balloon Catheter | Drug-coated balloon for the symptomatic cerebral atherosclerotic stenosis |
| DEVICE | Conventional Balloon | Conventional Balloon for the symptomatic cerebral atherosclerotic stenosis |
Timeline
- Start date
- 2024-05-27
- Primary completion
- 2025-07-27
- Completion
- 2026-07-27
- First posted
- 2024-11-12
- Last updated
- 2024-11-12
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06683118. Inclusion in this directory is not an endorsement.